https://scholars.lib.ntu.edu.tw/handle/123456789/564367
標題: | Synthetic lethality by lentiviral short hairpin RNA silencing of thymidylate kinase and doxorubicin in colon cancer cells regardless of the p53 status | 作者: | Hu C.-M. ZEE-FEN CHANG |
公開日期: | 2008 | 卷: | 68 | 期: | 8 | 起(迄)頁: | 2831-2840 | 來源出版物: | Cancer Research | 摘要: | Intracellular supply of dTTP is a highly regulated process and has been a key target for chemotherapeutic drug development. Thymidylate kinase (TMPK) is the key enzyme for dTTP formation in both de novo and salvage pathways. In this study, we used lentiviral-based small hairpin RNA to silence TMPK expression in p53(+/+) and p53(-/-) HCT-116 colon cancer cells. This approach was sufficient to decrease the dTTP pool gradually without affecting p53 expression and generating cytotoxicity. TMPK knockdown significantly increased doxorubicin sensitivity dramatically in p53-proficient, p53-null HCT-116, and LoVo colon cancer cells. The decrease in the dTTP pool using this approach augmented the DNA damage response and enhanced apoptotic induction after exposure to low-dose doxorubicin, leading to cell death. In contrast, silencin g of thymidylate synthase which blocks the de novo pathway was incapable of sensitizing p53-null HCT-116 cells to doxorubicin-induced apoptosis because of the compensation by the salvage pathway. Our results suggest the lentiviral delivery of small hairpin RNA targeting TMPK in combination with a low dose of doxorubicin as a new approach to kill colon cancer cells regardless of p53 status. ?2008 American Association for Cancer Research. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-42349114776&doi=10.1158%2f0008-5472.CAN-07-3069&partnerID=40&md5=e26e73df49805f6516d0c20c690ae938 https://scholars.lib.ntu.edu.tw/handle/123456789/564367 |
ISSN: | 0008-5472 | DOI: | 10.1158/0008-5472.CAN-07-3069 | SDG/關鍵字: | doxorubicin; lentivirus vector; short hairpin RNA; thymidine triphosphate; thymidylate synthase; apoptosis; article; cancer cell culture; cell killing; cell strain HCT116; colon cancer; concentration response; controlled study; culture medium; DNA damage; drug cytotoxicity; human; human cell; lethality; priority journal; protein expression; tumor suppressor gene; Antibodies, Monoclonal; Cell Line, Tumor; Colonic Neoplasms; DNA Damage; Doxorubicin; Gene Silencing; Genetic Vectors; Humans; Lentivirus; Nucleoside-Phosphate Kinase; RNA, Catalytic; RNA, Small Interfering; RNA, Viral; Tumor Suppressor Protein p53 |
顯示於: | 分子醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。